Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism

A 6-month-old kitten, male, domestic shorthair cat was presented with dwarfism, ocular and nasal discharge, and Ascaris infestation. Congenital hyposomatotropism was diagnosed on the basis of serum level of insulin-like growth factor-1 (IGF-I). The cat was treated with human recombinant growth hormo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Martina Načeradská, Kateřina Návojová Horáčková, Michaela Fridrichová
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	dwarfism human growth hormone cat hyposomatotropism IGF-I Veterinary medicine SF600-1100
Acceso en línea:	https://doaj.org/article/30eec9f265384961bb508d603d5d1869
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:30eec9f265384961bb508d603d5d1869
record_format	dspace
spelling	oai:doaj.org-article:30eec9f265384961bb508d603d5d18692021-11-22T05:13:42ZCase Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism2297-176910.3389/fvets.2021.773355https://doaj.org/article/30eec9f265384961bb508d603d5d18692021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fvets.2021.773355/fullhttps://doaj.org/toc/2297-1769A 6-month-old kitten, male, domestic shorthair cat was presented with dwarfism, ocular and nasal discharge, and Ascaris infestation. Congenital hyposomatotropism was diagnosed on the basis of serum level of insulin-like growth factor-1 (IGF-I). The cat was treated with human recombinant growth hormone for 9 weeks. After that, his liver enzymes became elevated, and the therapy was discontinued. His IGF-I levels were normal at the end of the therapy. Normal IGF-I was present 3 months after discontinuation of therapy with human recombinant growth hormone and even half a year after the discontinuation. All other comorbidities were addressed with the therapy. The cat is now the size of normal cats, living with the first author.Martina NačeradskáMartina NačeradskáKateřina Návojová HoráčkováMichaela FridrichováFrontiers Media S.A.articledwarfismhuman growth hormonecathyposomatotropismIGF-IVeterinary medicineSF600-1100ENFrontiers in Veterinary Science, Vol 8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	dwarfism human growth hormone cat hyposomatotropism IGF-I Veterinary medicine SF600-1100
spellingShingle	dwarfism human growth hormone cat hyposomatotropism IGF-I Veterinary medicine SF600-1100 Martina Načeradská Martina Načeradská Kateřina Návojová Horáčková Michaela Fridrichová Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism
description	A 6-month-old kitten, male, domestic shorthair cat was presented with dwarfism, ocular and nasal discharge, and Ascaris infestation. Congenital hyposomatotropism was diagnosed on the basis of serum level of insulin-like growth factor-1 (IGF-I). The cat was treated with human recombinant growth hormone for 9 weeks. After that, his liver enzymes became elevated, and the therapy was discontinued. His IGF-I levels were normal at the end of the therapy. Normal IGF-I was present 3 months after discontinuation of therapy with human recombinant growth hormone and even half a year after the discontinuation. All other comorbidities were addressed with the therapy. The cat is now the size of normal cats, living with the first author.
format	article
author	Martina Načeradská Martina Načeradská Kateřina Návojová Horáčková Michaela Fridrichová
author_facet	Martina Načeradská Martina Načeradská Kateřina Návojová Horáčková Michaela Fridrichová
author_sort	Martina Načeradská
title	Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism
title_short	Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism
title_full	Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism
title_fullStr	Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism
title_full_unstemmed	Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism
title_sort	case report: human recombinant growth hormone therapy in a dsh cat presented with dwarfism
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/30eec9f265384961bb508d603d5d1869
work_keys_str_mv	AT martinanaceradska casereporthumanrecombinantgrowthhormonetherapyinadshcatpresentedwithdwarfism AT martinanaceradska casereporthumanrecombinantgrowthhormonetherapyinadshcatpresentedwithdwarfism AT katerinanavojovahorackova casereporthumanrecombinantgrowthhormonetherapyinadshcatpresentedwithdwarfism AT michaelafridrichova casereporthumanrecombinantgrowthhormonetherapyinadshcatpresentedwithdwarfism
_version_	1718418152622129152

Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism

Ejemplares similares